Status:
COMPLETED
An Isolation Device to Contain Aerosol During Aerosol Generating Procedures in the Operating Room
Lead Sponsor:
John Shin
Conditions:
Aerosol Containment
Aerosol Generating Procedure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to test the safety and efficacy of a new isolation device to contain aerosol during aerosol-generating procedures in the operating room.
Detailed Description
Patients with SARS-CoV-2 infections may require procedures that generate infectious aerosols (suspension of tiny particles or droplets in the air). Aerosols are believed to be the primary method of sp...
Eligibility Criteria
Inclusion
- Elective scheduled surgery (not emergent)
- Planned general anesthesia requiring intubation
Exclusion
- Patients refusing or unable to consent for any reason, including claustrophobia or inability to cooperate
- Patients predicted to require the use of fiberoptic bronchoscopy for intubation
Key Trial Info
Start Date :
June 29 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2021
Estimated Enrollment :
79 Patients enrolled
Trial Details
Trial ID
NCT04864236
Start Date
June 29 2021
End Date
September 1 2021
Last Update
October 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA Medical Center
Los Angeles, California, United States, 90095